| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/10/2011 | US20110034545 Double-stranded lipid-modified rna having high rna interference effect |
| 02/10/2011 | US20110034541 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 02/10/2011 | US20110034538 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer |
| 02/10/2011 | US20110034537 Compositions and methods for inhibiting expression of cd45 gene |
| 02/10/2011 | US20110034534 siRNA compounds and methods of use thereof |
| 02/10/2011 | US20110034387 Polypeptide inhibiting angiogenesis and application thereof |
| 02/10/2011 | US20110034370 Bis-met histones |
| 02/10/2011 | US20110034368 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis |
| 02/10/2011 | US20110034349 siRNA targeting proto-oncogene MET |
| 02/10/2011 | US20110034345 Methods for diagnosis of maculopathies |
| 02/10/2011 | US20110033937 Down-regulation of gene expression using artificial micrornas |
| 02/10/2011 | US20110033921 Bardet-biedl susceptibility gene and uses thereof |
| 02/10/2011 | US20110033920 Compositions and methods for use in recombinational cloning of nucelic acids |
| 02/10/2011 | US20110033911 Episomal fusion gene |
| 02/10/2011 | US20110033900 Trichoderma Reesei Glucoamylase and Homologs Thereof |
| 02/10/2011 | US20110033895 Method For Producing Human Antibodies With Properties Of Agonist, Antagonist, or Inverse Agonist |
| 02/10/2011 | US20110033892 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 02/10/2011 | US20110033891 Mussel bioadhesive |
| 02/10/2011 | US20110033880 Fad-conjugated glucose dehydrogenase gene |
| 02/10/2011 | US20110033874 Biomarkers |
| 02/10/2011 | US20110033867 Use of biomarkers for detecting ovarian cancer |
| 02/10/2011 | US20110033860 Method For Searching Target Base Sequence Of Rna Interference, Method For Designing Base Sequence Of Polynucleotide For Causing Rna Interference, Method For Producing Double-Stranded Polynucleotide, Method For Inhibiting Gene Expression, Base Sequence Processing Apparatus, Program For Running Base Sequence Processing Method On Computer, Recording Medium, And Base Sequence Processing System |
| 02/10/2011 | US20110033858 siRNA DETECTION METHOD |
| 02/10/2011 | US20110033852 Present invention relates to methods for prediction of the therapeutic success of breast cancer therapy |
| 02/10/2011 | US20110033849 Ovine identification method |
| 02/10/2011 | US20110033840 Viral detection liposomes and method |
| 02/10/2011 | US20110033839 Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids |
| 02/10/2011 | US20110033838 Surface antigen protein mutant of hepatitis b virus surface antigen |
| 02/10/2011 | US20110033706 Nanocapsules and methods for modular assembly |
| 02/10/2011 | US20110033575 Pseudomonas saccharophila g4-amylase variants and uses thereof |
| 02/10/2011 | US20110033518 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase |
| 02/10/2011 | US20110033492 Vaccines for brucellosis |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033482 Her3 as a determinant for the prognosis of melanoma |
| 02/10/2011 | US20110033478 Canine thymic stromal lymphopoietin protein and uses thereof |
| 02/10/2011 | US20110033473 Anti influenza antibodies and uses thereof |
| 02/10/2011 | US20110033470 Human G-Protein Coupled Receptor |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033466 Human transcriptomes |
| 02/10/2011 | US20110033465 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 02/10/2011 | US20110033462 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (jev) and their use |
| 02/10/2011 | US20110033450 Antibody Against Anthrax Toxins |
| 02/10/2011 | US20110033448 Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids |
| 02/10/2011 | US20110033421 Methods related to immunostimulatory nucleic acid-induced interferon |
| 02/10/2011 | US20110033416 RNA Vaccines |
| 02/10/2011 | US20110033391 Transferases and Oxidoreductases, Nucleic Acids Encoding them and methods for making and using them |
| 02/10/2011 | US20110033389 Modified antibodies for passive immunotherapy |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |
| 02/10/2011 | CA2806295A1 Methods and compositions for treating insects |
| 02/10/2011 | CA2769756A1 Method for determining the presence and concentration of analytes using a nucleic acid ligand and rare earth element |
| 02/09/2011 | EP2281840A2 Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 02/09/2011 | EP2281826A1 Reagents, chaotropic agents, kits and methods for isolating nucleic acids based on magnetic cellulose materials |
| 02/09/2011 | EP2281798A1 Anthraquinone quencher dyes, their methods of preparation and use |
| 02/09/2011 | EP2281059A2 Method and apparatus for determining a probability of colorectal cancer in a subject |
| 02/09/2011 | EP2281040A2 Lyophilized dna formulations for enhanced expression of plasmid dna |
| 02/09/2011 | EP1725659B1 Natural igm antibodies and inhibitors thereof |
| 02/09/2011 | EP1636561B1 Combinatorial protein library screening by periplasmic expression |
| 02/09/2011 | EP1354060B1 5t4 rna in plasma and serum as a marker for neoplastic disease |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN1882602B The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| 02/09/2011 | CN101970662A Use of oligonucleotides with modified bases as antiviral agents |
| 02/09/2011 | CN101970451A Highly visible chromosome-specific probes and related methods |
| 02/09/2011 | CN101970443A Rna-selective hybridization reagent and utilization of the same |
| 02/09/2011 | CN101970051A Rna interference for the treatment of heart failure |
| 02/09/2011 | CN101550413B Method for extraction and purification of microbial total DNA of compost |
| 02/08/2011 | USRE42130 Phagemid vectors |
| 02/08/2011 | US7885767 Method, an installation, and a computer program for estimating the initial size of a population of nucleic acids, in particular by PCR |
| 02/08/2011 | US7884264 Transgenic plant which serves as bioreactor for expression of humanized glycoproteins with reduced fucose and xylose residues |
| 02/08/2011 | US7884262 Modified DMO enzyme and methods of its use |
| 02/08/2011 | US7884201 separate and purify RNA from leukocyte with good efficiency and high purity by destructing erythrocyte without destroying leukocyte |
| 02/08/2011 | US7884200 For carrying a target gene specific insert into a cell in order to modulate the expression of a target gene; modified Lentivirus vector; used to down-regulate the expression of a particular target gene within a cell |
| 02/08/2011 | US7884199 HCV NS3-NS4 protease resistance mutants |
| 02/08/2011 | US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 02/08/2011 | US7884197 oligonucleotide-based compounds that individually provide distinct immune response profiles through their interactions as agonists with Toll-like receptors (TLR9) |
| 02/08/2011 | US7884196 for induction and maintenance of regulator suppressor T cells resulting in suppression of non infectious, and post infectious, inflammatory, allergic, autoimmune, vasculitic, certain degenerative vascular, and graft versus host diseases, |
| 02/08/2011 | US7884190 Recombinant dimeric and heterodimeric proteins comprising amino acids 193 to 252 of the β chain of the human C4BP protein |
| 02/08/2011 | US7884086 identifying siRNA and double-stranded RNA compounds, having bioactivity in vivo; nucleosides |
| 02/08/2011 | US7884085 Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
| 02/08/2011 | US7884084 Oligonucleotide seqences for controlling expression of leptin receptor gene associated protein (OB-RGRP); for treatment and prevention of bone, thrombic, sexual, blood, immunological, inflammatory and cancer disorders |
| 02/08/2011 | US7884054 Methods for identifying functional antibodies |
| 02/08/2011 | US7884053 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation |
| 02/08/2011 | US7883895 capable of modulating exopolysaccharide production in Sphingomonas; using such nucleic acid sequences to generate bacteria that hyper-produce exopolysaccharide in slime form; produce exopolysaccharide in a form that does not increase the viscosity of a fermentation broth |
| 02/08/2011 | US7883883 Enzymes for starch processing |
| 02/08/2011 | US7883879 Ketoreductase polypeptides for the production of azetidinone |
| 02/08/2011 | US7883877 Compositions and methods for enhanced bacterial exopolysaccharide production |
| 02/08/2011 | US7883871 Compositions and methods for reverse transcriptase-polymerase chain reaction (RT-PCR) |
| 02/08/2011 | US7883870 Nucleotide sequences coding bacterial transcription factor for use in detection and characterization of staphylococcal subspecies |
| 02/08/2011 | US7883869 for sequencing single-stranded DNA by employing a nanopore and modified nucleotides |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883860 screening for modulators of human Ras palmitoyl acyl transfersase; drug screening |
| 02/08/2011 | US7883848 detecting molecular interaction networks such as affinity interactions or functional interactions; allow detection, interactor identification, and determination of relative strengths of all interactions possible within a library of interactors |
| 02/08/2011 | US7883712 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti |
| 02/08/2011 | US7883710 Peptide vaccines against Group A streptococci |
| 02/08/2011 | US7883696 deliver transgenes of interest and suppressors of the eukaryotic Type I interferon response to eukaryotic cells; Suppression of the eukaryotic Type I interferon response allows improved expression of the encoded transgene |
| 02/08/2011 | CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 02/08/2011 | CA2391433C Catalytic rnas with aminoacylation activity |
| 02/08/2011 | CA2260818C High fidelity detection of nucleic acid differences by ligase detection reaction |
| 02/08/2011 | CA2220830C Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/03/2011 | WO2011014659A2 Dual variable domain immunoglobulins and uses thereof |